Home › Researcher directory › K. Slimane
K. Slimane
Affiliation : Novartis (France)
- 1Publications (affiliation in France)
- 29Total publications
- 425Citations
- 7h-index
Research profile
K. Slimane has 1 indexed publication (2018). Their work appears in “Annals of Oncology”. Their most cited article, “Everolimus as first-line or after cytokine therapy in patients with metastatic recurrent and/or unresectable renal cell carcinoma (RCC) (EVE” (2018), has been cited 1 times.
Is this you? Get your research seen
Create your free DzCademia profile and add your articles: they will show up more easily on Google and in AI assistants like ChatGPT, so more people can read and cite your work.
Create my free profile Add my publicationsResearch areas
- Renal cell carcinoma treatment
- Breast Cancer Treatment Studies
- Bladder and Urothelial Cancer Treatments
- PI3K/AKT/mTOR signaling in cancer
- Advanced Breast Cancer Therapies
Publications (1)
Bibliographic data from OpenAlex (open database).
Why choose DzCademia?
Profiles, articles and conference contributions: give your research a structured public presence. Integrated metadata help search engines and AI assistants identify your work and understand its references.
Comment with Google
Sign in with Google to comment directly on this page.